BioSpecifics Technologies (BSTC) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Research and development: 312.91K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 312.91K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioSpecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.09, $0.03 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $2.7 million versus the consensus estimate of $2.91 million.
For earnings history and earnings-related data on BioSpecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
